-
The State Food and Drug Administration on the application of "M9: Bioequivalence Exemption Based on Biopharmaceutical Classification System" and Q&A documents and "Q5D: Source and Identification
Time of Update: 2021-05-22
After research, the National Medical Products Administration decided to apply "M9: Bioequivalence Exemption Based on Biopharmaceutical Classification System" and Q&A documents and "Q5D: Source and Identification of Cell Matrix Used in the Production of Biotechnology Products and Biological Products" Guidelines for the International Technical Coordination Committee on Drug Registration for Human Use (ICH).
-
Summary of 2020 annual performance reports of listed companies such as titanium dioxide
Time of Update: 2021-05-08
09%, and net profit attributable to shareholders of listed companies was 65,110,400 yuan, a year-on-year increase of 101.
The net profit attributable to shareholders of listed companies in 2020 is approximately 701 million yuan, a year-on-year increase of 34.
-
Daily review of epichlorohydrin: manufacturers make up for the increase
Time of Update: 2021-04-21
On the last trading day (August 11), the mainstream transaction price in the mainstream market in East China began to enter the range of 15,000 to 15,700 yuan/ton, and the high-end price increased by 200 yuan/ton.
-
The second domestic company, Junshi PD-1 urothelial carcinoma was approved for listing by NMPA
Time of Update: 2021-04-18
Two months ago, teriprizumab was approved for the second indication in China, the second-line treatment of patients with recurrent/metastatic nasopharyngeal carcinoma.
-
Health Commission: 8 newly diagnosed cases on the 27th were all imported from abroad
Time of Update: 2021-04-13
As of 24:00 on March 27, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 167 confirmed cases (including 1 severe case), a total of 85,364 cured and discharged cases, and a total of 4,636 deaths.
-
Epoxy weekly report: cost fluctuations
Time of Update: 2021-04-02
[China Epoxy Network (China Epoxy Industry Online) May 4, 2015: Week 04, April 2015 (April 27, 2015 ~ April 30, 2015) , The domestic epoxy resin market is inertially waiting and watching, trading is
-
GUT: If patients with acute pancreatitis are infected with the COVID-19 virus, the mortality rate will be greatly increased
Time of Update: 2021-03-30
The secondary outcome indicators were the cause of AP, intensive care unit (ICU) admission, length of stay, local complications, acute respiratory distress syndrome (ARDS), persistent organ failure and 30-day mortality.
-
Xinjiang Uygur Autonomous Region Market Supervision Administration Bureau of Food Safety Supervision Sampling Inspection Information Notice (No. 12 of 2021) No. 26 of 2021
Time of Update: 2021-03-30
html" class="zdbq" title="Food information related to national food safety standards" target="_blank">national food safety standard inspection and judgment, there are 634 batches of qualified samples and 13 batches of unqualified samples for foodmate.
-
BeiGene's CD3/CD19 dual-antibody new indications will be included in the priority review
Time of Update: 2021-03-27
Belinto Oumab was approved by the NMPA on December 4 last year through the priority review method for the treatment of adult relapsed or refractory precursor B-cell acute lymphoblastic leukemia (ALL).
-
Freshly released | 2021 SGO LBA blockbuster research solves the mystery
Time of Update: 2021-03-27
The study aims to explore the efficacy and safety of olaparib, olaparib+cediranib versus cediranib as a single agent for endometrial cancer patients.
The Phase Ib KEYNOTE-028 study showed that pembrolizumab showed certain anti-tumor activity in PD-L1-positive vulvar cancer patients with an ORR of 6%.
-
"Li" creates extraordinary, "Da" has a promising future│Taboshu® is launched in the new indication, rewriting the first-line treatment pattern of non-squamous NSCLC in China
Time of Update: 2021-03-26
In February 2021, Sintilimab was approved by the National Medical Products Administration (NMPA), and its indication is combined with pemetrexed and platinum-based chemotherapy for non-squamous NSCLC without EGFR sensitive mutations or ALK gene rearrangement First-line treatment.
-
Neurology: Lowering "good cholesterol" can increase the risk of Parkinson's disease by 60
Time of Update: 2021-03-21
Numerous previous studies have shown that there is an inverse relationship between a decrease in high-density lipoprotein cholesterol and an increased risk of coronary heart disease and myocardial infarction.
Reference: Association of High-Density Lipoprotein Cholesterol Variability and the Risk of Developing Parkinson Disease.
-
Dig Dis Sci: Impact of laparoscopic cholecystectomy on 30-day readmission for patients with acute cholangitis
Time of Update: 2021-03-20
1007/s10620-020-06240-3" target="_blank" rel="noopener">The Impact of Laparoscopic Cholecystectomy on 30-Day Readmission Rate for Acute Cholangitis Patients: A Single-Center Study.
1007/s10620-020-06240-3" target="_blank" rel="noopener">The Impact of Laparoscopic Cholecystectomy on 30-Day Readmission Rate for Acute Cholangitis Patients: A Single-Center Study.
-
Eur Radiol: tumor surface mucosal enhancement sign-a high-risk predictor of gastrointestinal stromal tumors
Time of Update: 2021-03-19
Table 2 Multivariate logistic regression analysis predicts the high-risk stratification of gastric stromal tumors.
Incomplete OEGM signs are an independent predictor of the high-risk stratification of gastric GISTs, and are closely related to pathological mucosal changes.
-
Observation of the phenomenon of plant light cycle
Time of Update: 2021-03-13
Under the condition of natural light, plants are artificially given short daylight, intermittent day, intermittent night and so on to understand the alternating day and night light and darkness and its length on the strong flowering of her ears, soybeans, rice and other short-day crops.
